Novo Nordisk
NVO
#22
Rank
โ‚น33.787 T
Marketcap
โ‚น7,249
Share price
-17.83%
Change (1 day)
-15.74%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): โ‚น1.489 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น39.69 Billion. In 2023 the company made an earning of โ‚น1.315 Trillion, an increase over its 2022 earnings that were of โ‚น834.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น1.489 T13.17%
2023 โ‚น1.315 T57.64%
2022 โ‚น834.71 B5.35%
2021 โ‚น792.32 B12.47%
2020 โ‚น704.47 B13.07%
2019 โ‚น623.04 B-3.35%
2018 โ‚น644.64 B1.79%
2017 โ‚น633.27 B4.52%
2016 โ‚น605.88 B9.42%
2015 โ‚น553.74 B8.24%
2014 โ‚น511.59 B3.45%
2013 โ‚น494.54 B19.02%
2012 โ‚น415.52 B15.21%
2011 โ‚น360.68 B17.71%
2010 โ‚น306.40 B24.78%
2009 โ‚น245.55 B10.62%
2008 โ‚น221.96 B55.97%
2007 โ‚น142.31 B7.07%
2006 โ‚น132.92 B18.18%
2005 โ‚น112.47 B11.33%
2004 โ‚น101.02 B
2002 โ‚น62.98 B-14.39%
2001 โ‚น73.56 B-52.82%
2000 โ‚น155.92 B250%
1999 โ‚น44.54 B31.21%
1998 โ‚น33.95 B34.31%
1997 โ‚น25.27 B11.46%
1996 โ‚น22.67 B9.03%
1995 โ‚น20.79 B-3.15%
1994 โ‚น21.47 B-0.67%
1993 โ‚น21.62 B45.38%
1992 โ‚น14.87 B-13.81%
1991 โ‚น17.25 B37.12%
1990 โ‚น12.58 B-0.79%
1989 โ‚น12.68 B26.2%
1988 โ‚น10.04 B24.97%
1987 โ‚น8.04 B-0.9%
1986 โ‚น8.11 B-7.78%
1985 โ‚น8.80 B24.87%
1984 โ‚น7.04 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น592.09 B-61.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น865.62 B-43.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น586.73 Billion-138.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น631.73 B-58.48%๐Ÿ‡ซ๐Ÿ‡ท France